Clinical guidelines panel on erectile dysfunction: Summary report on the treatment of organic erectile dysfunction

Drogo K. Montague, James H. Barada, Arnold M. Belker, Laurence A. Levine, Perry W. Nadig, Claus Roehrborn, Ira D. Sharlip, Alan H. Bennett

Research output: Contribution to journalArticle

176 Citations (Scopus)

Abstract

Purpose: The American Urological Association convened the Clinical Guidelines Panel on Erectile Dysfunction to analyze the literature regarding available methods for treating organic erectile dysfunction and to make practice recommendations based on the treatment outcomes data. Materials and Methods: The panel searched the MEDLINE data base for all articles from 1979 through 1994 on treatment of organic erectile dysfunction and meta-analyzed outcomes data for oral drug therapy (yohimbine), vacuum constriction devices, vasoactive drug injection therapy, penile prosthesis implantation and venous and arterial surgery. Results: Estimated probabilities of desirable outcomes are relatively high for vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis therapy. However, patients must be aware of potential complications. The outcomes data for yohimbine clearly indicate a therapy with marginal efficacy. For venous and arterial surgery, based on reported outcomes, chances of success do not appear high enough to justify routine use of such surgery. Conclusions: For the standard patient, defined as a man with acquired organic erectile dysfunction and no evidence of hypogonadism or hyperprolactinemia, the panel recommends 3 treatment alternatives: vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis implantation. Based on the data to date, yohimbine does not appear to be effective for organic erectile dysfunction and, thus, it should not be recommended as treatment for the standard patient. Venous surgery and arterial surgery in men with arteriolosclerotic disease are considered investigational and should be performed only in a research setting with long-term followup available.

Original languageEnglish (US)
Pages (from-to)2007-2011
Number of pages5
JournalJournal of Urology
Volume156
Issue number6
DOIs
StatePublished - Dec 1996

Fingerprint

Erectile Dysfunction
Guidelines
Yohimbine
Penile Implantation
Vacuum
Constriction
Drug Therapy
Equipment and Supplies
Injections
Penile Prosthesis
Therapeutics
Hyperprolactinemia
Hypogonadism
MEDLINE
Databases
Research

Keywords

  • impotence
  • penile erection

ASJC Scopus subject areas

  • Urology

Cite this

Clinical guidelines panel on erectile dysfunction : Summary report on the treatment of organic erectile dysfunction. / Montague, Drogo K.; Barada, James H.; Belker, Arnold M.; Levine, Laurence A.; Nadig, Perry W.; Roehrborn, Claus; Sharlip, Ira D.; Bennett, Alan H.

In: Journal of Urology, Vol. 156, No. 6, 12.1996, p. 2007-2011.

Research output: Contribution to journalArticle

Montague, DK, Barada, JH, Belker, AM, Levine, LA, Nadig, PW, Roehrborn, C, Sharlip, ID & Bennett, AH 1996, 'Clinical guidelines panel on erectile dysfunction: Summary report on the treatment of organic erectile dysfunction', Journal of Urology, vol. 156, no. 6, pp. 2007-2011. https://doi.org/10.1016/S0022-5347(01)65419-3
Montague, Drogo K. ; Barada, James H. ; Belker, Arnold M. ; Levine, Laurence A. ; Nadig, Perry W. ; Roehrborn, Claus ; Sharlip, Ira D. ; Bennett, Alan H. / Clinical guidelines panel on erectile dysfunction : Summary report on the treatment of organic erectile dysfunction. In: Journal of Urology. 1996 ; Vol. 156, No. 6. pp. 2007-2011.
@article{d235fa426acc4ecbb9fc1e983acfb7ca,
title = "Clinical guidelines panel on erectile dysfunction: Summary report on the treatment of organic erectile dysfunction",
abstract = "Purpose: The American Urological Association convened the Clinical Guidelines Panel on Erectile Dysfunction to analyze the literature regarding available methods for treating organic erectile dysfunction and to make practice recommendations based on the treatment outcomes data. Materials and Methods: The panel searched the MEDLINE data base for all articles from 1979 through 1994 on treatment of organic erectile dysfunction and meta-analyzed outcomes data for oral drug therapy (yohimbine), vacuum constriction devices, vasoactive drug injection therapy, penile prosthesis implantation and venous and arterial surgery. Results: Estimated probabilities of desirable outcomes are relatively high for vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis therapy. However, patients must be aware of potential complications. The outcomes data for yohimbine clearly indicate a therapy with marginal efficacy. For venous and arterial surgery, based on reported outcomes, chances of success do not appear high enough to justify routine use of such surgery. Conclusions: For the standard patient, defined as a man with acquired organic erectile dysfunction and no evidence of hypogonadism or hyperprolactinemia, the panel recommends 3 treatment alternatives: vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis implantation. Based on the data to date, yohimbine does not appear to be effective for organic erectile dysfunction and, thus, it should not be recommended as treatment for the standard patient. Venous surgery and arterial surgery in men with arteriolosclerotic disease are considered investigational and should be performed only in a research setting with long-term followup available.",
keywords = "impotence, penile erection",
author = "Montague, {Drogo K.} and Barada, {James H.} and Belker, {Arnold M.} and Levine, {Laurence A.} and Nadig, {Perry W.} and Claus Roehrborn and Sharlip, {Ira D.} and Bennett, {Alan H.}",
year = "1996",
month = "12",
doi = "10.1016/S0022-5347(01)65419-3",
language = "English (US)",
volume = "156",
pages = "2007--2011",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - Clinical guidelines panel on erectile dysfunction

T2 - Summary report on the treatment of organic erectile dysfunction

AU - Montague, Drogo K.

AU - Barada, James H.

AU - Belker, Arnold M.

AU - Levine, Laurence A.

AU - Nadig, Perry W.

AU - Roehrborn, Claus

AU - Sharlip, Ira D.

AU - Bennett, Alan H.

PY - 1996/12

Y1 - 1996/12

N2 - Purpose: The American Urological Association convened the Clinical Guidelines Panel on Erectile Dysfunction to analyze the literature regarding available methods for treating organic erectile dysfunction and to make practice recommendations based on the treatment outcomes data. Materials and Methods: The panel searched the MEDLINE data base for all articles from 1979 through 1994 on treatment of organic erectile dysfunction and meta-analyzed outcomes data for oral drug therapy (yohimbine), vacuum constriction devices, vasoactive drug injection therapy, penile prosthesis implantation and venous and arterial surgery. Results: Estimated probabilities of desirable outcomes are relatively high for vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis therapy. However, patients must be aware of potential complications. The outcomes data for yohimbine clearly indicate a therapy with marginal efficacy. For venous and arterial surgery, based on reported outcomes, chances of success do not appear high enough to justify routine use of such surgery. Conclusions: For the standard patient, defined as a man with acquired organic erectile dysfunction and no evidence of hypogonadism or hyperprolactinemia, the panel recommends 3 treatment alternatives: vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis implantation. Based on the data to date, yohimbine does not appear to be effective for organic erectile dysfunction and, thus, it should not be recommended as treatment for the standard patient. Venous surgery and arterial surgery in men with arteriolosclerotic disease are considered investigational and should be performed only in a research setting with long-term followup available.

AB - Purpose: The American Urological Association convened the Clinical Guidelines Panel on Erectile Dysfunction to analyze the literature regarding available methods for treating organic erectile dysfunction and to make practice recommendations based on the treatment outcomes data. Materials and Methods: The panel searched the MEDLINE data base for all articles from 1979 through 1994 on treatment of organic erectile dysfunction and meta-analyzed outcomes data for oral drug therapy (yohimbine), vacuum constriction devices, vasoactive drug injection therapy, penile prosthesis implantation and venous and arterial surgery. Results: Estimated probabilities of desirable outcomes are relatively high for vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis therapy. However, patients must be aware of potential complications. The outcomes data for yohimbine clearly indicate a therapy with marginal efficacy. For venous and arterial surgery, based on reported outcomes, chances of success do not appear high enough to justify routine use of such surgery. Conclusions: For the standard patient, defined as a man with acquired organic erectile dysfunction and no evidence of hypogonadism or hyperprolactinemia, the panel recommends 3 treatment alternatives: vacuum constriction devices, vasoactive drug injection therapy and penile prosthesis implantation. Based on the data to date, yohimbine does not appear to be effective for organic erectile dysfunction and, thus, it should not be recommended as treatment for the standard patient. Venous surgery and arterial surgery in men with arteriolosclerotic disease are considered investigational and should be performed only in a research setting with long-term followup available.

KW - impotence

KW - penile erection

UR - http://www.scopus.com/inward/record.url?scp=0029910170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029910170&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)65419-3

DO - 10.1016/S0022-5347(01)65419-3

M3 - Article

C2 - 8911378

AN - SCOPUS:0029910170

VL - 156

SP - 2007

EP - 2011

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 6

ER -